Novo Nordisk
NVO
NVO
1,503 hedge funds and large institutions have $33.4B invested in Novo Nordisk in 2023 Q4 according to their latest regulatory filings, with 286 funds opening new positions, 579 increasing their positions, 442 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,503
Holders Change
+201
Holders Change %
+15.44%
% of All Funds
22.03%
Holding in Top 10
69
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+11.29%
% of All Funds
1.01%
New
286
Increased
579
Reduced
442
Closed
59
Calls
$719M
Puts
$596M
Net Calls
+$123M
Net Calls Change
+$526M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.24B |
| 2 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$391M |
| 3 |
JPMorgan Chase & Co
New York
|
+$277M |
| 4 |
Amundi
Paris,
France
|
+$145M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$134M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$246M |
| 2 |
WCM Investment Management
Laguna Beach,
California
|
-$239M |
| 3 |
Jennison Associates
New York
|
-$92.2M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$82.8M |
| 5 |
BlackRock
New York
|
-$78M |
